Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease
- PMID: 16874665
- DOI: 10.14670/HH-21.1217
Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease
Abstract
Neurodegenerative disorders affecting the central nervous system, such as Alzheimer's disease, Parkinson's disease, Huntington's chorea (HD) and amyotrophic lateral sclerosis are characterized by the loss of selected neuronal populations. Another striking feature shared by these diseases is the deposition of proteinaceous inclusion bodies in the brain, which may be intracytoplasmatic or intranuclear, or even extracellular. However, the density and prevalence of aggregates are not always directly related to neurodegeneration. Although some of these diseases are the result of mutations in known proteins, with HD a clear example, the expression and location of the affected protein do not explain the selective neurodegeneration. Therefore, other intrinsic mechanisms, characteristic of each neuronal population, might be involved in the neurodegenerative process. In this review we focus on several proposed mechanisms such as excitotoxicity, mitochondrial dysfunction and altered expression of trophic factors, which could account for the pathogenesis of HD.
Similar articles
-
Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.J Neurochem. 2010 Jul;114(1):1-12. doi: 10.1111/j.1471-4159.2010.06741.x. Epub 2010 Apr 9. J Neurochem. 2010. PMID: 20403078 Review.
-
The selective vulnerability of nerve cells in Huntington's disease.Neuropathol Appl Neurobiol. 2001 Feb;27(1):1-21. doi: 10.1046/j.0305-1846.2001.00299.x. Neuropathol Appl Neurobiol. 2001. PMID: 11298997 Review.
-
Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.J Comp Neurol. 2007 Apr 10;501(5):716-30. doi: 10.1002/cne.21272. J Comp Neurol. 2007. PMID: 17299753
-
Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease.Mech Ageing Dev. 2006 May;127(5):432-5. doi: 10.1016/j.mad.2006.01.022. Epub 2006 Mar 9. Mech Ageing Dev. 2006. PMID: 16527334 Review.
-
Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.J Gene Med. 2012 Jul;14(7):468-81. doi: 10.1002/jgm.2641. J Gene Med. 2012. PMID: 22700462
Cited by
-
LIM homeodomain transcription factor-dependent specification of bipotential MGE progenitors into cholinergic and GABAergic striatal interneurons.Development. 2009 Nov;136(22):3841-51. doi: 10.1242/dev.038083. Development. 2009. PMID: 19855026 Free PMC article.
-
Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease.Hum Mol Genet. 2015 Sep 15;24(18):5285-98. doi: 10.1093/hmg/ddv248. Epub 2015 Jun 29. Hum Mol Genet. 2015. PMID: 26123489 Free PMC article.
-
Detection of axonal degeneration in a mouse model of Huntington's disease: comparison between diffusion tensor imaging and anomalous diffusion metrics.MAGMA. 2019 Aug;32(4):461-471. doi: 10.1007/s10334-019-00742-6. Epub 2019 Feb 15. MAGMA. 2019. PMID: 30771034 Free PMC article.
-
Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.J Neurosci. 2008 Oct 1;28(40):10090-101. doi: 10.1523/JNEUROSCI.3237-08.2008. J Neurosci. 2008. PMID: 18829967 Free PMC article.
-
Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.Mol Neurodegener. 2011 Oct 31;6:74. doi: 10.1186/1750-1326-6-74. Mol Neurodegener. 2011. PMID: 22041125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical